Form 4 for CORT CORCEPT THERAPEUTICS INC
Accepted 2022-09-01 00:00:00 ET · period of report 2022-08-30 · accession 0000899243-22-030201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-01 | 2022-08-30 | CORT | Robb Gary Charles | Chief Business Off | M - OptEx | $2.08 | +167.3K | 191.4K | +694% | +$348.0K |
| D | 2022-09-01 | 2022-08-30 | CORT | Robb Gary Charles | Chief Business Off | F - Tax | $26.14 | -93.9K | 97.5K | -49% | -$2.46M |
| D | 2022-09-01 | 2022-08-30 | CORT | Robb Gary Charles | Chief Business Off | M - OptEx | $0.00 | +167.3K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-30 | M | A | 167,323 | $2.08 | 191,446 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-30 | F | D | 93,922 | $26.14 | 97,524 | D | — | — | |
| 3 | Derivative | Stock option (right to buy) | 2022-08-30 | M | A | 167,323 | $0.00 | 0 | D | $2.08 · — to 2023-01-30 | 167,323 Common Stock | (F3) Fully exercisable. |